InsidersTradesSigma
Discover the full record of transactions filed by Girard Armand, Deputy Chief Executive. Officer active across 1 companies, notably Glycomimetics INC. In total, 1 disclosures have been logged. Total volume traded: €2k. The latest transaction was filed on 9 March 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Armand Girard is the Executive Vice President and Chief Business Officer at GlycoMimetics Inc. He oversees the commercial operations and growth strategy of the company. GlycoMimetics Inc. is a biopharmaceutical company focusing on developing treatments for serious diseases.